Molecule intelOpportunity: ModerateEssential

Latanoprost

75 brands · 27 companies · product forms

ATC: S01EE01

Opportunity snapshot

Launch attractiveness
35
Market saturation
78
Price room
82
Regulatory risk
0
75
brands
27
companies
Rs 883.18
median price
52
price points
4.26x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 8%

Price room

Across observed sources and strengths
CheapestRs 577.76
MedianRs 883.18
Most expensiveRs 2,458.44
Spread4.26×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 4.26x across 52 trusted points (Rs 577.76-2458.44). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 11 live products for Latanoprost — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(82) + 20% low-competition(22) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

27 canonical companies and 75 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 4.26x across 52 trusted points (Rs 577.76-2458.44). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.